The pill follows the blockbuster success of Novo Nordisk's Wegovy injection, which has been on the market since 2021 and became so popular that it was in short supply until February 2025
Common side effects (minimal) Most people: No side effects GHK-Cu extremely well-tolerated Natural peptide (found in body) Minimal adverse effects Possible minor effects: Injection site stinging (common, harmless) Minor bruising at injection sites Slight blue tint to injection site (copper, temporary) Mild headache (rare) Managing side effects: Stinging: Inject slowly, warm peptide to room temp Bruising: Rotate sites, proper technique Blue tint: Normal, fades within days Headache: Hydrate well, reduce dose Contraindications and cautions Avoid if: Pregnancy or breastfeeding (no data) Active cancer (theoretical copper concerns) Wilson's disease (copper metabolism disorder) Hemochromatosis (iron overload, copper caution) Use caution with: Copper supplements (avoid taking both) High copper foods (monitor intake) Liver disease (copper metabolism) Generally safe for: All ages (adults) Men and women Long-term use Most health conditions Copper toxicity concerns Is copper in GHK-Cu dangerous
On average, individuals taking Zepbound lost 15-20% of their body weight over the course of a year
Jurek and Castro-Marrero, 2024)
Mainly, I wanted to know whether it is even possible for GLP-1 drugs to have already lowered the national rate of obesity in the United States
This aids in regulating blood sugar, reducing hunger, and promoting a feeling of satiety by slowing down the digestion process
.jpg?ver=1765877054)
-1456x816.jpg.webp)
